News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,642 Results
Type
Article (39462)
Company Profile (306)
Press Release (648874)
Section
Business (204806)
Career Advice (2005)
Deals (35482)
Drug Delivery (87)
Drug Development (81005)
Employer Resources (168)
FDA (16119)
Job Trends (14865)
News (345853)
Policy (32553)
Tag
Academia (2548)
Alliances (49436)
Alzheimer's disease (1237)
Approvals (16050)
Artificial intelligence (130)
Bankruptcy (354)
Best Places to Work (11561)
Biotechnology (217)
Breast cancer (121)
Cancer (1089)
Cardiovascular disease (97)
Career advice (1673)
Cell therapy (236)
Clinical research (64380)
Collaboration (390)
Compensation (200)
COVID-19 (2546)
C-suite (95)
Data (1127)
Diabetes (153)
Diagnostics (6160)
Earnings (84951)
Employer resources (146)
Events (110025)
Executive appointments (310)
FDA (16660)
Funding (356)
Gene therapy (178)
GLP-1 (581)
Government (4342)
Healthcare (18694)
Infectious disease (2631)
Inflammatory bowel disease (110)
Interviews (308)
IPO (16337)
Job creations (3663)
Job search strategy (1430)
Layoffs (417)
Legal (7888)
Lung cancer (170)
Manufacturing (177)
Medical device (13186)
Medtech (13191)
Mergers & acquisitions (19224)
Metabolic disorders (404)
Neuroscience (1514)
NextGen Class of 2024 (6538)
Non-profit (4477)
Northern California (1484)
Obesity (232)
Opinion (183)
Patents (102)
People (56605)
Phase I (20017)
Phase II (28367)
Phase III (21132)
Pipeline (458)
Postmarket research (2555)
Preclinical (8526)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5937)
Regulatory (21594)
Research institute (2316)
Resumes & cover letters (350)
Southern California (1308)
Startups (3617)
United States (13549)
Vaccines (551)
Weight loss (169)
Date
Today (79)
Last 7 days (671)
Last 30 days (3738)
Last 365 days (35810)
2024 (32864)
2023 (40178)
2022 (51290)
2021 (55841)
2020 (54158)
2019 (46650)
2018 (35134)
2017 (32231)
2016 (31637)
2015 (37719)
2014 (31464)
2013 (26511)
2012 (28776)
2011 (29431)
2010 (27525)
Location
Africa (719)
Arizona (192)
Asia (37349)
Australia (6112)
California (3350)
Canada (1296)
China (253)
Colorado (148)
Connecticut (153)
Europe (80037)
Florida (461)
Georgia (116)
Illinois (344)
Indiana (198)
Kansas (97)
Maryland (576)
Massachusetts (2619)
Michigan (158)
Minnesota (273)
New Jersey (957)
New York (965)
North Carolina (703)
Northern California (1484)
Ohio (141)
Pennsylvania (849)
South America (1098)
Southern California (1308)
Texas (468)
Utah (90)
Washington State (363)
688,642 Results for "crown biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
October 2, 2024
·
2 min read
Biotech Beach
Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services
Crown Bioscience today announced the dual attainment of College of American Pathologists (CAP) accreditations for its medical laboratory services.
April 11, 2024
·
2 min read
Mergers & acquisitions
Crown Laboratories to Buy Botox Rival Revance Therapeutics for $924M
The acquisition announced Monday will give Crown access to Revance’s Daxxify, a competitor to AbbVie’s Botox, which is indicated for frown lines and for cervical dystonia.
August 13, 2024
·
2 min read
·
Tristan Manalac
Biotech Beach
Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, will showcase significant contributions in preclinical and translational oncology research at the American Association for Cancer Research (AACR) 2024 meeting.
March 28, 2024
·
2 min read
Business
Crown Laboratories Announces Appointment of Matt Argano, Ph.D. as Chief Human Resources Officer
Crown Laboratories (“Crown”), a fully integrated global skincare company, announced today that Matt Argano , Ph.D. has joined the organization as Chief Human Resources Officer.
May 13, 2024
·
2 min read
BioMidwest
Crown Laboratories, Inc. Announces Strategic Consolidation of Business Units to Form a Unified Consumer Skincare Division
In a strategic move to streamline operations and harness the collective expertise of its team, Crown Laboratories, Inc., a leader in skin science for life, announced the consolidation of its Premium Skincare and Therapeutic business units into a single, robust Consumer Skincare Division.
February 27, 2024
·
2 min read
Biotech Beach
Crown Bioscience’s Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations
Crown Bioscience , a global contract research organization (CRO) and JSR Life Sciences company, proudly announces that its global laboratory facilities have successfully passed a series of annual on-site ISO audits, achieving a flawless record with zero discrepancies.
January 23, 2024
·
2 min read
Biotech Beach
Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening
Crown Bioscience announced the launch of its ground-breaking service offering, OrganoidXploreTM.
November 7, 2023
·
3 min read
Bio NC
Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
Pfizer Inc. announced longer-term follow-up results from the Phase 3 CROWN trial evaluating LORBRENA® versus XALKORI® in people with previously untreated, anaplastic lymphoma kinase -positive advanced non-small cell lung cancer.
May 31, 2024
·
23 min read
Press Releases
Crown Laboratories and Revance Announce Entry Into Merger Agreement
August 12, 2024
·
10 min read
1 of 68,865
Next
